Academic Journals Database
Disseminating quality controlled scientific knowledge

Current Controlled Trials in Cardiovascular Medicine

ISSN: 1468--6708
Publisher: BioMed Central


ADD TO MY LIST
 
Debate: Statins should be used in patients with heart failure

Author(s): Kjekshus John
Volume: 2
Issue: 6
Year: 2001
Debate: Should statin be used in patients with heart failure?

Author(s): Pietro Maggioni Aldo
Volume: 2
Issue: 6
Year: 2001
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?

Author(s): Gavras Irene | Gavras Haralambos
Volume: 2
Issue: 6
Year: 2001
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)

Author(s): Thijs Lutgarde | Staessen Jan | Beleva Sonia | Birkenhäger Willem | Bulpitt Christopher | Celis Hilde | Fletcher Astrid | Kermova Rumjana | Leonetti Gastone | Laks Tovio | Mantov Stefan | Nachev Choudomir | Sarti Cinzia | Tuomilehto Jaakko | Fagard Robert
Volume: 2
Issue: 6
Year: 2001
Biventricular pacing in heart failure: update on results from clinical trials

Author(s): Haywood Guy
Volume: 2
Issue: 6
Year: 2001
Therapeutic angiogenesis for cardiovascular disease

Author(s): Ng Yin-Shan | D'Amore Patricia
Volume: 2
Issue: 6
Year: 2001
Comments on ALLHAT and doxazosin

Author(s): Krakoff Lawrence
Volume: 2
Issue: 6
Year: 2001
Cytokines as new treatment targets in chronic heart failure

Author(s): Damås Jan | Gullestad Lars | Aukrust Pål
Volume: 2
Issue: 6
Year: 2001
Distal protection devices during percutaneous coronary and carotid interventions

Author(s): Fasseas Panayotis | Orford James | Denktas Ali | Berger Peter
Volume: 2
Issue: 6
Year: 2001
Debate: PCI vs CABG: a moving target, but we are gaining

Author(s): Holmes David
Volume: 2
Issue: 6
Year: 2001
A new era in hypertension research: discussing the findings of ALLHAT

Author(s): Furberg Curt
Volume: 2
Issue: 6
Year: 2001
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight

Author(s): Bhatt Deepak | Topol Eric
Volume: 2
Issue: 6
Year: 2001
Arterial indications for the low molecular weight heparins

Author(s): Ageno Walter | Huisman Menno
Volume: 2
Issue: 5
Year: 2001
Withdrawal of cerivastatin from the world market

Author(s): Furberg Curt | Pitt Bertram
Volume: 2
Issue: 5
Year: 2001
Diuretics: again the first step in the treatment of most patients with hypertension

Author(s): Fuchs Flávio
Volume: 2
Issue: 5
Year: 2001
Anti-atherogenic effects of fibrates in type 2 diabetes

Author(s): Barter Philip
Volume: 2
Issue: 5
Year: 2001
ELITE II and Val-HeFT are different trials: together what do they tell us?

Author(s): Dickstein Kenneth
Volume: 2
Issue: 5
Year: 2001
Cardiac rehabilitation: a comprehensive review

Author(s): Lear Scott | Ignaszewski Andrew
Volume: 2
Issue: 5
Year: 2001
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study

Author(s): Mahaffey Kenneth | Harrington Robert | Akkerhuis Martijn | Kleiman Neal | Berdan Lisa | Crenshaw Brian | Tardiff Barbara | Granger Christopher | DeJong Ingrid | Bhapkar Manju | Widimsky Petr | Corbalon Ramón | Lee Kerry | Deckers Jaap | Simoons Maarten | Topol Eric | Califf Robert
Volume: 2
Issue: 4
Year: 2001
Systematic adjudication of myocardial infarction end-points in an international clinical trial

Author(s): Mahaffey Kenneth | Harrington Robert | Akkerhuis Martijn | Kleiman Neal | Berdan Lisa | Crenshaw Brian | Tardiff Barbara | Granger Christopher | DeJong Ingrid | Bhapkar Manju | Widimsky Petr | Corbalon Ramón | Lee Kerry | Deckers Jaap | Simoons Maarten | Topol Eric | Califf Robert
Volume: 2
Issue: 4
Year: 2001
Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding

Author(s): Hobson Robert | Howard Virginia | Brott Thomas | Howard George | Roubin Gary | Ferguson Robert
Volume: 2
Issue: 4
Year: 2001
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Author(s): Suwaidi Jassim | Salam Amar
Volume: 2
Issue: 4
Year: 2001
The role of dyslipidemia and statins in venous thromboembolism

Author(s): Ray Joel | Rosendaal Frits
Volume: 2
Issue: 4
Year: 2001
Dose response of ACE inhibitors: implications of the SECURE trial

Author(s): Lonn Eva
Volume: 2
Issue: 4
Year: 2001
Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women

Author(s): Ray Joel | Langman Loralie | Vermeulen Marian | Evrovski Jovan | Yeo Erik | Cole David
Volume: 2
Issue: 3
Year: 2001
A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease

Author(s): Gylling Helena | Miettinen Tatu
Volume: 2
Issue: 3
Year: 2001
Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial [ISRCTN19943732]

Author(s): Bradford Andrew | Lees Kennedy
Volume: 1
Issue: 3
Year: 2000
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

Author(s): Kobashigawa Jon
Volume: 1
Issue: 3
Year: 2000
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?

Author(s): White Harvey
Volume: 1
Issue: 3
Year: 2000
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention

Author(s): ten Berg Jurriën | Plokker HW | Verheugt Freek
Volume: 2
Issue: 3
Year: 2001
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?

Author(s): Waters David | Schwartz Gregory | Olsson Anders
Volume: 2
Issue: 3
Year: 2001
Bridging case-control studies and randomized trials

Author(s): Rosendaal Frits
Volume: 2
Issue: 3
Year: 2001
Are statins anti-inflammatory?

Author(s): Blake Gavin | Ridker Paul
Volume: 1
Issue: 3
Year: 2000
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?

Author(s): Algra Ale | van Gijn Jan
Volume: 1
Issue: 3
Year: 2000
Exercise training in heart failure

Author(s): Coats Andrew
Volume: 1
Issue: 3
Year: 2000
Debate: The potential role of estrogen in the prevention of heart disease in women after menopause

Author(s): Johnson Rebecca | Sweeney Mary
Volume: 1
Issue: 3
Year: 2000
Beta-Adrenergic gene therapy for cardiovascular disease

Author(s): Eckhart Andrea | Koch Walter
Volume: 1
Issue: 3
Year: 2000
Implications of troponin testing in clinical medicine

Author(s): Goldmann Britta | Christenson Robert | Hamm Christian | Meinertz Thomas | Ohman E Magnus
Volume: 2
Issue: 2
Year: 2001
New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products

Author(s): Vollmer William | Sacks Frank | Svetkey Laura
Volume: 2
Issue: 2
Year: 2001
Ablation of atrial fibrillation: a procedure come of age?

Author(s): Wharton J Marcus
Volume: 2
Issue: 2
Year: 2001
Debate: does it matter how you lower blood pressure?

Author(s): McInnes Gordon
Volume: 2
Issue: 2
Year: 2001
Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy

Author(s): Seggewiss Hubert
Volume: 1
Issue: 2
Year: 2000
Pacing in congestive heart failure

Author(s): Morris-Thurgood Jayne | Frenneaux Michael
Volume: 1
Issue: 2
Year: 2000
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?

Author(s): Hsia Henry | Jessup Mariell | Marchlinski Francis
Volume: 1
Issue: 2
Year: 2000
Clinical applicability of molecular biology: the case of the long QT syndrome

Author(s): Schwartz Peter
Volume: 1
Issue: 2
Year: 2000
Debate: The slippery slope of surrogate outcomes

Author(s): D'Agostino Ralph
Volume: 1
Issue: 2
Year: 2000
Angiotensin receptor blockers in heart failure after the ELITE II trial

Author(s): Willenheimer Ronnie
Volume: 1
Issue: 2
Year: 2000
Debate: Are surrogate end-point studies worth the effort?

Author(s): Valabhji Jonathan | Elkeles Robert S
Volume: 1
Issue: 2
Year: 2000
Low-molecular-weight heparins in the treatment of venous thromboembolism

Author(s): Ageno Walter | Huisman Menno
Volume: 1
Issue: 2
Year: 2000
Debate: Does it matter how you lower blood pressure?

Author(s): Alderman Michael
Volume: 1
Issue: 2
Year: 2000
No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months

Author(s): Willenheimer Ronnie | Juul-Möller Steen | Forslund Lennart | Erhardt Leif
Volume: 2
Issue: 2
Year: 2001
Gene therapy for lipid disorders

Author(s): Kawashiri Masa-aki | Rader Daniel J
Volume: 1
Issue: 2
Year: 2000
An essential guide to the literature

Author(s): Penny William | Bourke John
Volume: 1
Issue: 2
Year: 2000
Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate

Author(s): Dietz Ulrich | Dauer Cheryl | Lambertz Heinz
Volume: 6
Issue: 1
Year: 2005
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review

Author(s): Scharplatz Madlaina | Puhan Milo | Steurer Johann | Perna Annalisa | Bachmann Lucas
Volume: 6
Issue: 1
Year: 2005
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction

Author(s): Turer Aslan | Mahaffey Kenneth | Gallup Dianne | Weaver W Douglas | Christenson Robert | Every Nathan | Ohman E Magnus
Volume: 6
Issue: 1
Year: 2005
Coronary artery bypass surgery in high-risk patients

Author(s): Kunt Alper | Darcın Osman | Andac Mehmet
Volume: 6
Issue: 1
Year: 2005
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study

Author(s): Fellström Bengt | Zannad Faiez | Schmieder Roland | Holdaas Hallvard | Jardine Alan | Rose Helen | Wilpshaar Wim
Volume: 6
Issue: 1
Year: 2005
Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation

Author(s): Diedrichs Holger | Zobel Carsten | Theissen Peter | Weber Michael | Koulousakis Athanassios | Schicha Harald | Schwinger Robert
Volume: 6
Issue: 1
Year: 2005
Exercise training improves aerobic endurance and musculoskeletal fitness in female cardiac transplant recipients

Author(s): Haykowsky Mark | Riess Kenneth | Figgures Linda | Kim Daniel | Warburton Darren | Jones Lee | Tymchak Wayne
Volume: 6
Issue: 1
Year: 2005
Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]

Author(s): Penne E Lars | Blankestijn Peter | Bots Michiel | van den Dorpel Marinus | Grooteman Muriel | Nubé Menso | van der Tweel Ingeborg | ter Wee Piet
Volume: 6
Issue: 1
Year: 2005
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]

Author(s): Ostadal Petr | Alan David | Hajek Petr | Vejvoda Jiri | Mates Martin | Blasko Peter | Veselka Josef | Kvapil Milan | Kettner Jiri | Wiendl Martin | Aschermann Ondrej | Slaby Josef | Nemecek Eduard | Holm Frantisek | Rac Marek | Macek Milan | Cepova Jana
Volume: 6
Issue: 1
Year: 2005
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors

Author(s): Espeland Mark | O'Leary Daniel | Terry James | Morgan Timothy | Evans Greg | Mudra Harald
Volume: 6
Issue: 1
Year: 2005
Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma

Author(s): Tengiz Istemihan | Ercan Ertugrul | Sahin Fahri | Alioglu Emin | Duman Can | Saydam Guray | Buyukkececi Filiz
Volume: 6
Issue: 1
Year: 2005
Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study

Author(s): Tengiz Istemihan | Ercan Ertugrul | Aliyev Emil | Sekuri Cevad | Duman Can | Altuglu Imre
Volume: 5
Issue: 1
Year: 2004
Balancing commercial and public interests

Author(s): Furberg Curt | Hall Mark | Sevick Mary
Volume: 5
Issue: 1
Year: 2004
Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases

Author(s): Yetkin Ufuk | Karabay Özalp | Önol Hakan
Volume: 5
Issue: 1
Year: 2004
Effects of a comprehensive cardiac rehabilitation program on quality of life and exercise tolerance in women: A retrospective analysis

Author(s): Kennedy Michael | Haykowsky Mark | Daub Bill | van Lohuizen Karen | Knapik Grant | Black Bill
Volume: 4
Issue: 1
Year: 2003
A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data

Author(s): Lear Scott | Ignaszewski Andrew | Linden Wolfgang | Brozic Anka | Kiess Marla | Spinelli John | Pritchard P Haydn | Frohlich Jiri
Volume: 3
Issue: 1
Year: 2002
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

Author(s): Piller Linda | Davis Barry | Cutler Jeffrey | Cushman William | Wright Jackson | Williamson Jeff | Leenen Frans | Einhorn Paula | Randall Otelio | Golden John | Haywood L Julian
Volume: 3
Issue: 1
Year: 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics

Author(s): Ford Ian | Blauw Gerard | Murphy Michael | Shepherd James | Cobbe Stuart | Bollen Edward | Buckley Brendan | Jukema J Wouter | Hyland Michael | Gaw Allan | Lagaay A Margot | Perry Ivan | Macfarlane Peter | Norrie John | Meinders A Edo | Sweeney Brian | Packard Chris | Westendorp Rudi | Twomey Cillian | Stott David
Volume: 3
Issue: 1
Year: 2002
A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy

Author(s): Bryson Chris | Psaty Bruce
Volume: 3
Issue: 1
Year: 2002
Pooling, meta-analysis, and the evaluation of drug safety

Author(s): Lièvre Michel | Cucherat Michel | Leizorovicz Alain
Volume: 3
Issue: 1
Year: 2002
Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors

Author(s): Chiabrando Chiara | Avanzini Fausto | Rivalta Claudia | Colombo Fabio | Fanelli Roberto | Palumbo Gaetana | Roncaglioni Maria
Volume: 3
Issue: 1
Year: 2002
Weight-modification trials in older adults: what should the outcome measure be?

Author(s): Diehr Paula | Newman Anne | Jackson Sharon | Kuller Lewis | Powe Neil
Volume: 3
Issue: 1
Year: 2002
Clinical significance of cardiovascular dysmetabolic syndrome

Author(s): Deedwania Prakash
Volume: 3
Issue: 1
Year: 2002
New immunosuppressive drugs in heart transplantation

Author(s): Costanzo Maria Rosa
Volume: 2
Issue: 1
Year: 2001
Experience collecting interim data on mortality: an example from the RALES study

Author(s): Wittes Janet | Palensky Jolie | Asner Debra | Julian Desmond | Boissel Jean-Pierre | Furberg Curt | Kulbertus Henri | Pocock Stuart | Roniker Barbara
Volume: 2
Issue: 1
Year: 2001
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"

Author(s): Fazio Sergio | Linton MacRae
Volume: 2
Issue: 1
Year: 2001
Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial

Author(s): Theroux Pierre | Chaitman Bernard | Erhardt Leif | Jessel Andreas | Meinertz Thomas | Nickel Wolf-Ulrich | Schroeder John | Tognoni Gianni | White Harvey | Willerson James
Volume: 1
Issue: 1
Year: 2000
Debate: Unstable angina - When should we intervene?

Author(s): Kereiakes Dean
Volume: 1
Issue: 1
Year: 2000
Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm

Author(s): Urbonavicius Sigitas | Vorum Henrik | Urbonaviciene Grazina | Trumpickas Mindaugas | Pavalkis Dainius | Honoré Bent
Volume: 6
Issue: 1
Year: 2005
Problems in dealing with missing data and informative censoring in clinical trials

Author(s): Shih Weichung
Volume: 3
Issue: 1
Year: 2002
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

Author(s): Eichhorn Eric | Bristow Michael
Volume: 2
Issue: 1
Year: 2001
The Proliferation REduction with Vascular ENergy Trial (PREVENT)

Author(s): Raizner Albert | Kaluza Grzegorz
Volume: 2
Issue: 1
Year: 2001
The current status of primary prevention in coronary heart disease

Author(s): Pater Cornel
Volume: 2
Issue: 1
Year: 2001
Fundamental deficiencies in the megatrial methodology

Author(s): Charlton Bruce G
Volume: 2
Issue: 1
Year: 2001
Use of intravenous antiarrhythmics to identify concealed Brugada syndrome

Author(s): Brugada Ramon
Volume: 1
Issue: 1
Year: 2000
Why do antioxidants fail to provide clinical benefit?

Author(s): Warnholtz Ascan | Münzel Thomas
Volume: 1
Issue: 1
Year: 2000
Long-term outcome after coronary stenting

Author(s): Kastrati Adnan | Hall Donald | Schömig Albert
Volume: 1
Issue: 1
Year: 2000
Medical errors: how the US Government is addressing the problem

Author(s): Schulman Kevin | Kim John
Volume: 1
Issue: 1
Year: 2000
Importance of the TIMI frame count: implications for future trials

Author(s): Appleby Mark | Michaels Andrew | Chen Michael | Michael C Gibson
Volume: 1
Issue: 1
Year: 2000
Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?

Author(s): Vosberg Hans-Peter
Volume: 1
Issue: 1
Year: 2000
Compliance of a cobalt chromium coronary stent alloy – the COVIS trial

Author(s): Hagemeister Jens | Baer Frank | Schwinger Robert | Höpp Hans
Volume: 6
Issue: 1
Year: 2005
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran

Author(s): Boos Christopher | More Ranjit
Volume: 5
Issue: 1
Year: 2004
Informative noncompliance in endpoint trials

Author(s): Snapinn Steven | Jiang Qi | Iglewicz Boris
Volume: 5
Issue: 1
Year: 2004
Are there fundamental deficiencies in the megatrial methodology?

Author(s): Julian Desmond | Furberg Curt
Volume: 2
Issue: 1
Year: 2001
Debate: When should we intervene in unstable angina - Time for an old look?

Author(s): Laskey Warren
Volume: 1
Issue: 1
Year: 2000
Debate: A subversive view of subsets - a dissident clinician's opinion

Author(s): Julian Desmond
Volume: 1
Issue: 1
Year: 2000
Noninferiority trials

Author(s): Snapinn Steven
Volume: 1
Issue: 1
Year: 2000
'No independent link' between diabetes and poor outcomes after CABG/PTCA

Author(s): Lyford Joanna | Ghali WA | Quan H | Norris CM | Dzavik V | Naylor CD | Mitchell LB | Brant R | Knudtson ML
Volume: 2
Year: 2000
Statins reduce dementia risk by 70%

Author(s): Lyford Joanna | Jick H | Zornberg GL | Jick SS | Seshadri S | Drachman DA
Volume: 2
Year: 2000
Sudden vigorous exercise associated with increased risk of death

Author(s): Lyford Joanna | Albert CM | Mittleman MA | Chae CU | Lee IM | Hennekens CH | Manson JE
Volume: 2
Year: 2000
Evidence for increased risk of venous thrombosis during air travel

Author(s): Lyford Joanna | Bendz B | Rostrup M | Sevre K | Andersen TO | Sandset PM
Volume: 2
Year: 2000
Different mechanisms by which CMV predisposes to CAD in men and women

Author(s): Lyford Joanna | Zhu J | Shearer GM | Norman JE | Pinto LA | Marincola FM | Prasad A | Waclawiw MA | Csako G | Quyyumi AA | Epstein SE
Volume: 2
Year: 2000
Plaque morphology directly related to platelet activation in ACS

Author(s): Lyford Joanna | Chakhtoura EY | Shamoon FE | Haft JI | Obiedzinski GR | Cohen AJ | Watson RM
Volume: 2
Year: 2000
Multi-drug risk reduction strategy safe in peripheral artery disease

Author(s): Lyford Joanna | Garg R | Elam MB | Crouse JR | Davis KB | Kennedy JW | Egan D | Herd JA | Hunninghake DB | Johnson WC | Kostis JB | Sheps DS | Applegate WB
Volume: 2
Year: 2000
Metoprolol vs carvedilol in heart failure

Author(s): Norton Michael | Metra M | Giubbini R | Nodari S | Boldi E | Modena MG | Dei Cas LD
Volume: 2
Year: 2000
Intravenous dofetilide vs amiodarone

Author(s): Mulvahill Niall | Bianconi L | Castro A | Dinelli M | Alboni P | Pappalardo A | Santini M
Volume: 2
Year: 2000
Amiodarone as a first choice drug

Author(s): Mulvahill Niall | Vardos PE | Kochiadakis GE | Igoumenidis NE | Tsatsakis AM | Simantriakis EN | Chlouverakis GI
Volume: 2
Year: 2000
Effects of alcohol consumption in patients with left ventricular dysfunction

Author(s): Irvine T | Cooper A | Exner DV | Domanski MJ
Volume: 2
Year: 2000
Orbofiban in unstable angina (OPUS-TIMI 16 trial)

Author(s): Ellis Gethin | Cannon CP | McCabe CH | Wilcox RG | Langer A | Caspi A | Berink P | Lopez-Sendon J | Toman J | Charlesworth A | Anders RJ | Alexander RJ | Skene A | Braunwald E
Volume: 2
Year: 2000
Intracoronary radiation for in-stent restenosis

Author(s): Malenkianpoor Mehrdad | Teirstein PS | Massullo V | Schatz RA | Guarneri EM | Steuterman S | Sirkin K | Cloutier DA | Leon MB | Tripuraneni P
Volume: 2
Year: 2000
Major study finds no link between gum disease and CV risk

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Community-based study highlights sex differential in post-MI mortality

Author(s): Lyford Joanna
Volume: 2
Year: 2001
More evidence for inflammatory markers in predicting CHD risk

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Epifibatide is justified in community hospital treatment of ACS

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Statins not effective in reducing osteoporotic fractures

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Lack of effect of HRT on stroke/TIA risk 'not surprising'

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Diastolic dysfunction as predominant form of CHF confirmed

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Noninvasive tests for CAD unsuitable in renal failure patients

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Diabetes and insulin use on AMI survival - is enough being done?

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Diabetic AMI patients receive suboptimal thrombolytic treatment

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Tamoxifen is not associated with increased CV event rate

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Sudden vigorous exercise associated with increased risk of death

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Evidence for increased risk of venous thrombosis during air travel

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Tamoxifen may reduce CHD risk via inflammatory mediators

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Caerphilly study finds no link between homocysteine and CHD

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Prognostic value of ultrasonographic measurements in stable angina

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Dietary changes take two years to reduce heart attack risk

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Patients with AMI continue to delay hospital presentation

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Statins reduce dementia risk by 70%

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Different mechanisms by which CMV predisposes to CAD in men and women

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Plaque morphology directly related to platelet activation in ACS

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Multi-drug risk reduction strategy safe in peripheral artery disease

Author(s): Lyford Joanna
Volume: 2
Year: 2001
Intravenous dofetilide vs amiodarone

Author(s): Mulvahill Niall
Volume: 2
Year: 2001
Metoprolol vs carvedilol in heart failure

Author(s): Norton Michael
Volume: 2
Year: 2001
Amiodarone as a first choice drug

Author(s): Mulvahill Niall
Volume: 2
Year: 2001
Orbofiban in unstable angina (OPUS-TIMI 16 trial)

Author(s): Ellis Gethin
Volume: 2
Year: 2001
Intracoronary radiation for in-stent restenosis

Author(s): Malenkianpoor Mehrdad
Volume: 2
Year: 2001
Save time & money - Smart Internet Solutions      Why do you need a reservation system?